CN103690643A - Medicine for treating cardiovascular and cerebrovascular diseases and preparation method thereof - Google Patents
Medicine for treating cardiovascular and cerebrovascular diseases and preparation method thereof Download PDFInfo
- Publication number
- CN103690643A CN103690643A CN201410000303.3A CN201410000303A CN103690643A CN 103690643 A CN103690643 A CN 103690643A CN 201410000303 A CN201410000303 A CN 201410000303A CN 103690643 A CN103690643 A CN 103690643A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- radix
- raw material
- cardiovascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating cardiovascular and cerebrovascular diseases, which is prepared from the following raw materials: radix panacis quinquefolii, radix notoginseng, radix salviae miltiorrhizae, lucid ganoderma, cortex eucommiae, cortex acanthopanacis, fructus crataegi, herba leonuri, uncaria rhynchophylla and earthworm. The invention also provides a preparation method of the medicine, which comprises the following steps of preparing the following raw materials in parts by weight: 5-25 parts of radix panacis quinquefolii, 15-35 parts of radix notoginseng, 15-40 parts of radix salviae miltiorrhizae, 15-40 parts of lucid ganoderma, 20-45 parts of cortex eucommiae, 20-50 parts of cortex acanthopanacis, 15-40 parts of fructus crataegi, 25-45 parts of herba leonuri, 25-45 parts of uncaria rhynchophylla and 15-40 parts of earthworm; grinding the raw materials into powder; making the ground raw materials into pills, granules, powder or capsules. The medicine disclosed by the invention combines the pharmacological effects of the traditional Chinese medicinal materials to realize a synergistic effect, and can soften the blood vessels and reduce hyperglycemia, hyperlipidemia and hypertension, so that the blood flows smoothly in blood vessels to thoroughly treat the cardiovascular and cerebrovascular diseases.
Description
Technical field
The present invention relates to Chinese medicine technical field, relate in particular to a kind of medicine that is used for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof.
Background technology
Cardiovascular and cerebrovascular disease is a kind of serious threat mankind, the commonly encountered diseases of 50 years old above middle-aged and elderly people health particularly, and the number of cardiovascular and cerebrovascular disease is died from every year up to 1,500 ten thousand people in the whole world, occupies the various causes of the death the first.At present, China's Patients with Cardiovascular/Cerebrovascular Diseases has surpassed 2.7 hundred million people, dies from every year nearly 3,000,000 people of cardiovascular and cerebrovascular disease, accounts for 51% of the annual total Death causes of China.
The pathogenic factor of cardiovascular and cerebrovascular disease mainly contains following several: 1. hypertension, and long-term hypertension can make cerebral artery vessel wall thickening or hardening, and tube chamber attenuates.When blood pressure rises sharply, the cerebrovascular generation cerebral hemorrhage that easily breaks; Or the microaneurysm of the brain small artery having hardened formation chestnut grain size, when fluctuations in blood, arteriole stream breaks and causes cerebral hemorrhage; Or hypertension quickening arteriosclerosis process, arterial endothelial cell liquid sustains damage, and platelet is easily assembled in injury, easily forms again cerebral thrombosis, causes cardiovascular and cerebrovascular disease.2. hyperlipidemia, modern life rhythm is nervous, and the pressure of family, cause is increasing, and people's emotion is also more and more unstable; Simultaneously, excessive consumption of alcohol, take in too many food fat, lack necessary motion, in addition the pollution of living environment, airborne anion concentration sharply declines, and the anion of taking in body is also just not enough, these factors directly cause human body rate of metabolism to slow down, velocity of blood flow can slow down, and blood viscosity raises rapidly, causes cerebral ischemia, if prevent not in time, nurse one's health, will cause the cardiovascular and cerebrovascular diseases such as coronary heart disease, hypertension, cerebral thrombosis, fatty liver; 3. the improper metabolism of vascular smooth muscle cell.As everyone knows, its hetero-organization of vascular tissue and human body is the same completes metabolic process in some cycles, but because new cell tissue can not form normally, so easily the vasoconstriction of generation inflammation is not smooth to make blood vessel wall itself have " defect ", similarly be a worm-eaten old pipeline, have at any time the possibility of blocking or breaking.
From the above, hypertension, hyperlipidemia and hyperglycemia (three-hypers) are the main causes that causes cardiovascular and cerebrovascular disease, therefore in existing treatment, mostly adopt the means of falling three-hypers to prevent and treat.The medicament categories that is used at present falling three-hypers is various, mostly for the medication that reduces blood pressure, by medicine, by vasodilation, makes bloody path unimpeded.But distend the blood vessels for a long time, shrink, blood vessel is gradually benumbed medicine, finally make effect of drugs reduce or lost efficacy, and that blood vessel is not still realized is unimpeded, cause that the hidden danger of cardiovascular and cerebrovascular disease can not be eliminated.
Summary of the invention
For overcoming the deficiencies in the prior art, the object of the present invention is to provide a kind of preparation method of effectively treating medicine and this medicine of cardiovascular and cerebrovascular disease by vessel softening.
According to an aspect of the present invention, provide a kind of medicine for the treatment of cardiovascular and cerebrovascular disease, by following raw material, made: Radix Panacis Quinquefolii, Radix Notoginseng, Radix Salviae Miltiorrhizae, Ganoderma, the Cortex Eucommiae, Cortex Acanthopancis, Fructus Crataegi, Herba Leonuri, Ramulus Uncariae Cum Uncis, Pheretima.
Alternatively, according to the medicine for the treatment of cardiovascular and cerebrovascular disease of the present invention, the weight proportion of described raw material is Radix Panacis Quinquefolii 5-25 part, Radix Notoginseng 15-35 part, Radix Salviae Miltiorrhizae 15-40 part, Ganoderma 15-40 part, Cortex Eucommiae 20-45 part, Cortex Acanthopancis 20-50 part, Fructus Crataegi 15-40 part, Herba Leonuri 25-45 part, Ramulus Uncariae Cum Uncis 25-45 part, Pheretima 15-40 part.
Alternatively, according to the medicine for the treatment of cardiovascular and cerebrovascular disease of the present invention, the weight proportion of described raw material is Radix Panacis Quinquefolii 10-15 part, Radix Notoginseng 20-25 part, Radix Salviae Miltiorrhizae 20-30 part, Ganoderma 20-30 part, Cortex Eucommiae 30-35 part, Cortex Acanthopancis 30-40 part, Fructus Crataegi 20-30 part, Herba Leonuri 30-35 part, Ramulus Uncariae Cum Uncis 30-40 part, Pheretima 20-30 part.
Alternatively, according to the medicine for the treatment of cardiovascular and cerebrovascular disease of the present invention, the weight proportion of described raw material is 12 parts of Radix Panacis Quinquefoliis, 23 parts, Radix Notoginseng, 25 parts of Radix Salviae Miltiorrhizaes, 25 parts of Ganodermas, 32 parts of the Cortexs Eucommiae, 35 parts of Cortex Acanthopanciss, 25 parts of Fructus Crataegis, 33 parts of Herba Leonuris, 35 parts of Ramulus Uncariae Cum Uncis, 25 parts of Pheretimas.
Alternatively, according to the medicine for the treatment of cardiovascular and cerebrovascular disease of the present invention, described medicine also comprises the raw material of following weight proportion: Periostracum Cicadae 20-30 part and Herba Apocyni veneti 20-30 part.
Alternatively, according to the medicine for the treatment of cardiovascular and cerebrovascular disease of the present invention, the weight proportion of described each raw material is 12 parts of Radix Panacis Quinquefoliis, 23 parts, Radix Notoginseng, 25 parts of Radix Salviae Miltiorrhizaes, 24 parts of Ganodermas, 32 parts of the Cortexs Eucommiae, 35 parts of Cortex Acanthopanciss, 25 parts of Fructus Crataegis, 33 parts of Herba Leonuris, 35 parts of Ramulus Uncariae Cum Uncis, 25 parts of Pheretimas, 25 parts of Periostracum Cicadaes, 26 parts of Herba Apocyni venetis.
Alternatively, according to the medicine for the treatment of cardiovascular and cerebrovascular disease of the present invention, described medicine is pill, granule, powder or capsule.
According to a further aspect in the invention, provide a kind of preparation method for the treatment of cardiovascular and cerebrovascular diseases medicament, comprised the following steps:
Prepare raw material Radix Panacis Quinquefolii 5-25 part, Radix Notoginseng 15-35 part, Radix Salviae Miltiorrhizae 15-40 part, 15-40 weight portion Ganoderma, Cortex Eucommiae 20-45 part, Cortex Acanthopancis 20-50 part, Fructus Crataegi 15-40 part, Herba Leonuri 25-45 part, Ramulus Uncariae Cum Uncis 25-45 part, Pheretima 15-40 part of following weight proportion; By described raw material pulverizing powdered; Raw material after described pulverizing is made to pill, granule, powder or capsule.
Alternatively, preparation in accordance with the present invention, also comprises 20-30 weight portion Periostracum Cicadae and 20-30 weight portion Herba Apocyni veneti in described raw material.
Alternatively, preparation in accordance with the present invention, described raw material is ground into 20-50 object powder.
The performance of each raw material of Chinese medicine using in said medicine is as follows:
Radix Panacis Quinquefolii: blood pressure is had to Accommodation, make temporary or persistency blood pressure drops, suppress arteriosclerosis and promote Growth of red blood cells, increase the deal of hematochrome, diabetics is regulated in addition to the effect of blood glucose.
Radix Notoginseng: there is promoting blood circulation to remove blood stasis effect, energy antiplatelet aggregation, antithrombotic forms, and flavone compound wherein has effect, sitosterol and the blood fat reducing of daucosterol energy that improves blood supply of cardiac muscle, increases blood vessel elasticity, coronary artery dilator.
Radix Salviae Miltiorrhizae: TANSHINONES can be expanded the coronary artery of human body, increases coronary flow, improves myocardial ischemia, infraction and heart, regulates the rhythm of the heart, and can expand peripheral blood vessel, improves microcirculation, reduces blood glucose, blood pressure effect.
Ganoderma: coronary artery dilator effectively, increase coronary flow, improve Myocardial Microcirculation, strengthen the supply of myocardium oxygen and energy, myocardial ischemia is had to protective effect; To high fat of blood patient, Ganoderma can obviously reduce cholesterolemia, lipoprotein and triglyceride, and the formation of energy prevention of arterial atherosclerotic plaque; For atherosclerotic plaque former, have and reduce Arterial Cholesterol content, vessel softening, prevent the further effect of damage.
Cortex Acanthopancis: reduce whole blood viscosity, atherosclerosis formation.
Fructus Crataegi: blood fat reducing, blood pressure, heart tonifying and arrhythmia.
Herba Leonuri: heart tonifying, increase coronary flow and myocardial nutritional flow amount.
The Cortex Eucommiae: regulate blood pressure, recover blood vessel elasticity.
Ramulus Uncariae Cum Uncis: reduce blood pressure.
Pheretima: dredge the meridian passage, blood circulation promoting and blood stasis dispelling, can angiocardiopathy preventing.
Periostracum Cicadae: loose wind dehumidifying.
Herba Apocyni veneti: blood pressure lowering, heart tonifying.
Medicine of the present invention be take Radix Panacis Quinquefolii as monarch drug, Radix Notoginseng, Radix Salviae Miltiorrhizae are adjuvant drug, the Cortex Eucommiae, Cortex Acanthopancis, Ganoderma etc. are for making medicine, pharmacological effect in conjunction with various Chinese crude drugs, performance synergism, can vessel softening and reduce hyperglycemia, hyperlipidemia and hypertension, make blood unimpeded in blood vessel, thoroughly treat cardiovascular and cerebrovascular disease.
Accompanying drawing explanation
By reading below detailed description of the preferred embodiment, various other advantage and benefits will become cheer and bright for those of ordinary skills.Accompanying drawing is only for the object of preferred implementation is shown, and do not think limitation of the present invention.In the accompanying drawings:
Fig. 1 is the preparation flow figure for the treatment of cardiovascular and cerebrovascular diseases medicament of the present invention.
The specific embodiment
Below in conjunction with accompanying drawing and concrete embodiment, the invention will be further described.
One aspect of the present invention provides a kind of medicine for the treatment of cardiovascular and cerebrovascular disease, by following raw material, is made: Radix Panacis Quinquefolii, Radix Notoginseng, Radix Salviae Miltiorrhizae, Ganoderma, the Cortex Eucommiae, Cortex Acanthopancis, Fructus Crataegi, Herba Leonuri, Ramulus Uncariae Cum Uncis, Pheretima are made.Particularly, the weight proportion of described raw material is Radix Panacis Quinquefolii 5-25 part, Radix Notoginseng 15-35 part, Radix Salviae Miltiorrhizae 15-40 part, Ganoderma 15-40 part, Cortex Eucommiae 20-45 part, Cortex Acanthopancis 20-50 part, Fructus Crataegi 15-40 part, Herba Leonuri 25-45 part, Ramulus Uncariae Cum Uncis 25-45 part, Pheretima 15-40 part.Preferably, the weight proportion of described raw material is Radix Panacis Quinquefolii 10-15 part, Radix Notoginseng 20-25 part, Radix Salviae Miltiorrhizae 20-30 part, Ganoderma 20-30 part, Cortex Eucommiae 30-35 part, Cortex Acanthopancis 30-40 part, Fructus Crataegi 20-30 part, Herba Leonuri 30-35 part, Ramulus Uncariae Cum Uncis 30-40 part, Pheretima 20-30 part.More preferably, the weight proportion of described raw material is 12 parts of Radix Panacis Quinquefoliis, 23 parts, Radix Notoginseng, 25 parts of Radix Salviae Miltiorrhizaes, 25 parts of Ganodermas, 32 parts of the Cortexs Eucommiae, 35 parts of Cortex Acanthopanciss, 25 parts of Fructus Crataegis, 33 parts of Herba Leonuris, 35 parts of Ramulus Uncariae Cum Uncis, 25 parts of Pheretimas.
Except the raw material of above-mentioned weight proportion, described medicine also comprises the raw material of following weight proportion: Periostracum Cicadae 20-30 part and Herba Apocyni veneti 20-30 part, be preferably 25 parts of Periostracum Cicadaes, 26 parts of Herba Apocyni venetis.
The present invention also provides the preparation method of above-mentioned treatment cardiovascular and cerebrovascular diseases medicament on the other hand.Fig. 1 shows the preparation flow figure that is used for the treatment of cardiovascular and cerebrovascular diseases medicament of the present invention.As shown in Figure 1, first prepare raw material Radix Panacis Quinquefolii 5-25 part, Radix Notoginseng 15-35 part, Radix Salviae Miltiorrhizae 15-40 part, 15-40 weight portion Ganoderma, Cortex Eucommiae 20-45 part, Cortex Acanthopancis 20-50 part, Fructus Crataegi 15-40 part, Herba Leonuri 25-45 part, Ramulus Uncariae Cum Uncis 25-45 part, Pheretima 15-40 part of following weight proportion; Described medicine also comprises the raw material of following weight proportion: Periostracum Cicadae 20-30 part and Herba Apocyni veneti 20-30 part.After having prepared burden, by the raw material pulverizing powdered of above-mentioned weight proportion, the particle diameter of powder is generally 20-50 order left and right and is advisable.Finally the Raw material processing after described pulverizing is become to the portable dosage forms such as pill, granule, powder or capsule.Be understandable that, except above-mentioned dosage form, this medicine can also be processed to any existing pharmaceutical dosage forms such as injection, transfusion, injectable powder, tablet, slow releasing tablet as required, and described formulation means adopt routine techniques means in prior art.
The proportioning raw materials of the treatment cardiovascular and cerebrovascular diseases medicament proposing according to the present invention can be designed various embodiments, so specific embodiment is only as the exemplary illustration of specific implementation of the present invention, and does not form limitation of the scope of the invention.For concrete description the present invention, select following examples to carry out exemplary illustration.
Embodiment 1
The medicine of the present embodiment treatment cardiovascular and cerebrovascular disease is made by the raw material of Chinese medicine of following weight proportion: 5 parts of Radix Panacis Quinquefoliis, 30 parts, Radix Notoginseng, 40 parts of Radix Salviae Miltiorrhizaes, 30 parts of Ganodermas, 20 parts of the Cortexs Eucommiae, 50 parts of Cortex Acanthopanciss, 30 parts of Fructus Crataegis, 40 parts of Herba Leonuris, 45 parts of Ramulus Uncariae Cum Uncis, 15 parts of Pheretimas.
The raw material powder of above-mentioned weight proportion is broken into 30 object powder, then, by the agent of dusty raw materials granulation, then according to the specification of every bag of 10-15g, the granule making is packed, when patient takes, granule is taken after mixing it with water.
Embodiment 2
The medicine of the present embodiment treatment cardiovascular and cerebrovascular disease is made by the raw material of Chinese medicine of following weight proportion: 12 parts of Radix Panacis Quinquefoliis, 23 parts, Radix Notoginseng, 25 parts of Radix Salviae Miltiorrhizaes, 25 parts of Ganodermas, 32 parts of the Cortexs Eucommiae, 35 parts of Cortex Acanthopanciss, 25 parts of Fructus Crataegis, 33 parts of Herba Leonuris, 35 parts of Ramulus Uncariae Cum Uncis, 25 parts of Pheretimas.
The raw material powder of above-mentioned weight proportion is broken into 20 object powder, then dusty raw materials is made to pill, the weight of described each pill is 10-15g, and patient is each serving with a pill.
Embodiment 3
The medicine of the present embodiment treatment cardiovascular and cerebrovascular disease is made by the raw material of Chinese medicine of following weight proportion: 20 parts of Radix Panacis Quinquefoliis, 35 parts, Radix Notoginseng, 15 parts of Radix Salviae Miltiorrhizaes, 15 parts of Ganodermas, 45 parts of the Cortexs Eucommiae, 20 parts of Cortex Acanthopanciss, 40 parts of Fructus Crataegis, 25 parts of Herba Leonuris, 30 parts of Ramulus Uncariae Cum Uncis, 30 parts of Pheretimas.
The raw material powder of above-mentioned weight proportion is broken into 25 object powder, then dusty raw materials is made to powder, then according to the specification of every bag of 10-15g, the powder making is packed, patient takes after mixing it with water.
Embodiment 4
The medicine of the present embodiment treatment cardiovascular and cerebrovascular disease is made by the raw material of Chinese medicine of following weight proportion: 25 parts of Radix Panacis Quinquefoliis, 15 parts, Radix Notoginseng, 30 parts of Radix Salviae Miltiorrhizaes, 40 parts of Ganodermas, 25 parts of the Cortexs Eucommiae, 40 parts of Cortex Acanthopanciss, 15 parts of Fructus Crataegis, 45 parts of Herba Leonuris, 25 parts of Ramulus Uncariae Cum Uncis, 40 parts of Pheretimas, 20 parts of Periostracum Cicadaes, 30 parts of Herba Apocyni venetis.
The raw material powder of above-mentioned weight proportion is broken into 35 object powder, then dusty raw materials is made to capsule, each capsule contains raw material 10-15g, and patient is each serving with a pill.
Embodiment 5
The medicine of the present embodiment treatment cardiovascular and cerebrovascular disease is made by the raw material of Chinese medicine of following weight proportion: 12 parts of Radix Panacis Quinquefoliis, 23 parts, Radix Notoginseng, 25 parts of Radix Salviae Miltiorrhizaes, 25 parts of Ganodermas, 32 parts of the Cortexs Eucommiae, 35 parts of Cortex Acanthopanciss, 25 parts of Fructus Crataegis, 33 parts of Herba Leonuris, 35 parts of Ramulus Uncariae Cum Uncis, 25 parts of Pheretimas, 25 parts of Periostracum Cicadaes, 26 parts of Herba Apocyni venetis.
The raw material powder of above-mentioned weight proportion is broken into 50 object powder, then dusty raw materials is made to pill, the weight of described each pill is 10-15g, and patient is each serving with a pill.
Embodiment 6
The medicine of the present embodiment treatment cardiovascular and cerebrovascular disease is made by the raw material of Chinese medicine of following weight proportion: 12 parts of Radix Panacis Quinquefoliis, 23 parts, Radix Notoginseng, 25 parts of Radix Salviae Miltiorrhizaes, 25 parts of Ganodermas, 32 parts of the Cortexs Eucommiae, 35 parts of Cortex Acanthopanciss, 25 parts of Fructus Crataegis, 33 parts of Herba Leonuris, 35 parts of Ramulus Uncariae Cum Uncis, 25 parts of Pheretimas, 30 parts of Periostracum Cicadaes, 20 parts of Herba Apocyni venetis.
The raw material powder of above-mentioned weight proportion is broken into 40 object powder, then dusty raw materials is made to powder, then according to the specification of every bag of 10-15g, the powder making is packed, patient takes after mixing it with water.
The medicine preparing through above-described embodiment 1-6 can vessel softening, and then effectively effects a radical cure cardiovascular and cerebrovascular disease.The effect of medicines of the present invention is described with 3 concrete cases below.
Case 1
Tang, 65 years old, man, retired professor, because cerebral infarction causes hemiplegia, dyslalia.Take medicine of the present invention, each 10-15g, an order three times.After three months, language expression celadon, can descend to walk by crutch.
Case 2
Huge certain, 58 years old, female, retired worker, suffers from cerebral infarction and heart disease, extremity are handicapped.Take medicine of the present invention, each 10-15g, three times on the one.After two months, extremity freedom of movement, the heart disease state of an illness is clearly better.
Case 3
Lee, man, 48 years old, Enterprise Staff, suffered from coronary heart disease, time have a pain outbreak, with collapse, perspiration, cardiopalmus, feel sick or the symptom such as dizzy symptom.Take medicine of the present invention, each 10-15g, three times on the one.After three months, angina pectoris symptom alleviates, and morbidity number of times is obviously less.Through health check-up, blood pressure obviously reduces.
It should be noted, the present invention will be described rather than limit the invention for above-described embodiment, and those skilled in the art can design alternative embodiment in the situation that do not depart from the scope of claims.In the claims, any reference marks between bracket should be configured to limitations on claims.Word " comprises " not to be got rid of existence and is not listed as element or operation in the claims.
Claims (10)
1. treat a medicine for cardiovascular and cerebrovascular disease, by following raw material, made: Radix Panacis Quinquefolii, Radix Notoginseng, Radix Salviae Miltiorrhizae, Ganoderma, the Cortex Eucommiae, Cortex Acanthopancis, Fructus Crataegi, Herba Leonuri, Ramulus Uncariae Cum Uncis, Pheretima.
2. the medicine for the treatment of cardiovascular and cerebrovascular disease according to claim 1, is characterized in that: the weight proportion of described raw material is Radix Panacis Quinquefolii 5-25 part, Radix Notoginseng 15-35 part, Radix Salviae Miltiorrhizae 15-40 part, Ganoderma 15-40 part, Cortex Eucommiae 20-45 part, Cortex Acanthopancis 20-50 part, Fructus Crataegi 15-40 part, Herba Leonuri 25-45 part, Ramulus Uncariae Cum Uncis 25-45 part, Pheretima 15-40 part.
3. the medicine for the treatment of cardiovascular and cerebrovascular disease according to claim 2, is characterized in that: the weight proportion of described raw material is Radix Panacis Quinquefolii 10-15 part, Radix Notoginseng 20-25 part, Radix Salviae Miltiorrhizae 20-30 part, Ganoderma 20-30 part, Cortex Eucommiae 30-35 part, Cortex Acanthopancis 30-40 part, Fructus Crataegi 20-30 part, Herba Leonuri 30-35 part, Ramulus Uncariae Cum Uncis 30-40 part, Pheretima 20-30 part.
4. the medicine for the treatment of cardiovascular and cerebrovascular disease according to claim 2, is characterized in that: the weight proportion of described raw material is 12 parts of Radix Panacis Quinquefoliis, 23 parts, Radix Notoginseng, 25 parts of Radix Salviae Miltiorrhizaes, 25 parts of Ganodermas, 32 parts of the Cortexs Eucommiae, 35 parts of Cortex Acanthopanciss, 25 parts of Fructus Crataegis, 33 parts of Herba Leonuris, 35 parts of Ramulus Uncariae Cum Uncis, 25 parts of Pheretimas.
5. the medicine for the treatment of cardiovascular and cerebrovascular disease according to claim 2, is characterized in that: described medicine also comprises the raw material of following weight proportion: Periostracum Cicadae 20-30 part and Herba Apocyni veneti 20-30 part.
6. the medicine for the treatment of cardiovascular and cerebrovascular disease according to claim 5, is characterized in that: the weight proportion of described each raw material is 12 parts of Radix Panacis Quinquefoliis, 23 parts, Radix Notoginseng, 25 parts of Radix Salviae Miltiorrhizaes, 24 parts of Ganodermas, 32 parts of the Cortexs Eucommiae, 35 parts of Cortex Acanthopanciss, 25 parts of Fructus Crataegis, 33 parts of Herba Leonuris, 35 parts of Ramulus Uncariae Cum Uncis, 25 parts of Pheretimas, 25 parts of Periostracum Cicadaes, 26 parts of Herba Apocyni venetis.
7. according to the medicine of the treatment cardiovascular and cerebrovascular disease described in any one in claim 1-6, it is characterized in that: described medicine is pill, granule, powder or capsule.
8. a preparation method for the treatment of cardiovascular and cerebrovascular diseases medicament, comprises the following steps:
Prepare raw material Radix Panacis Quinquefolii 5-25 part, Radix Notoginseng 15-35 part, Radix Salviae Miltiorrhizae 15-40 part, 15-40 weight portion Ganoderma, Cortex Eucommiae 20-45 part, Cortex Acanthopancis 20-50 part, Fructus Crataegi 15-40 part, Herba Leonuri 25-45 part, Ramulus Uncariae Cum Uncis 25-45 part, Pheretima 15-40 part of following weight proportion;
By described raw material pulverizing powdered;
Raw material after described pulverizing is made to pill, granule, powder or capsule.
9. preparation method according to claim 8, is characterized in that: in described raw material, also comprise 20-30 weight portion Periostracum Cicadae and 20-30 weight portion Herba Apocyni veneti.
10. preparation method according to claim 8 or claim 9, is characterized in that: described raw material is ground into 20-50 object powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410000303.3A CN103690643B (en) | 2014-01-02 | 2014-01-02 | A kind of medicine for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410000303.3A CN103690643B (en) | 2014-01-02 | 2014-01-02 | A kind of medicine for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103690643A true CN103690643A (en) | 2014-04-02 |
| CN103690643B CN103690643B (en) | 2016-03-23 |
Family
ID=50352413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410000303.3A Expired - Fee Related CN103690643B (en) | 2014-01-02 | 2014-01-02 | A kind of medicine for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103690643B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189440A (en) * | 2014-09-20 | 2014-12-10 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine capsule for treating cerebral thrombosis |
| CN108310188A (en) * | 2018-05-10 | 2018-07-24 | 湖南康尔佳制药股份有限公司 | A kind of Chinese medicine composition and preparation method for treating angiocardiopathy |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101020028A (en) * | 2006-11-11 | 2007-08-22 | 刘光辉 | Chinese medicine for treating cardiac and cerebral vascular diseases |
| CN102499971A (en) * | 2012-01-06 | 2012-06-20 | 黑龙江新医圣制药有限责任公司 | Sugar-free brain-nourishing tablet for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
-
2014
- 2014-01-02 CN CN201410000303.3A patent/CN103690643B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101020028A (en) * | 2006-11-11 | 2007-08-22 | 刘光辉 | Chinese medicine for treating cardiac and cerebral vascular diseases |
| CN102499971A (en) * | 2012-01-06 | 2012-06-20 | 黑龙江新医圣制药有限责任公司 | Sugar-free brain-nourishing tablet for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 石景洋等: "缺血性脑血管病治疗中中药应用频次及临床分析", 《时珍国医国药》, vol. 24, no. 10, 31 December 2013 (2013-12-31), pages 2464 - 2467 * |
| 赵国民等: "定风汤治疗中风先兆的临床观察", 《中国中医药科技》, vol. 2, no. 2, 31 December 1995 (1995-12-31), pages 38 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189440A (en) * | 2014-09-20 | 2014-12-10 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine capsule for treating cerebral thrombosis |
| CN108310188A (en) * | 2018-05-10 | 2018-07-24 | 湖南康尔佳制药股份有限公司 | A kind of Chinese medicine composition and preparation method for treating angiocardiopathy |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103690643B (en) | 2016-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101507765B (en) | Medicine for treating cerebrovascular disease and sequela thereof and preparation method thereof | |
| CN101843661A (en) | Chinese medicament for treating angina | |
| CN103690643B (en) | A kind of medicine for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof | |
| CN102357195A (en) | Medicinal composition for treating cardiovascular and cerebrovascular diseases, and preparation method and application thereof | |
| CN101810337A (en) | Health food containing pseudo-ginseng and ganoderma lucidum and radix astragali | |
| CN104189819B (en) | A kind of Chinese medicine preparation for being used to nurse one's health emotional health | |
| CN102342985A (en) | Chinese medicinal prescription for treating chloasma | |
| CN103495115B (en) | A kind of to the medicative medicated wine of diabetes tool | |
| CN106902317A (en) | It is a kind of to treat Chinese medicine composition of depression and preparation method thereof | |
| CN104107242B (en) | A kind of Chinese medicine composition for the treatment of hyperthyroidism and its production and use | |
| CN107812102A (en) | A kind of pharmaceutical composition for treating cardiovascular and cerebrovascular disease and preparation method thereof, preparation and application | |
| CN101843644B (en) | Chinese medicament for treating tachycardia | |
| CN101843753B (en) | Chinese medicament for treating angina | |
| CN101843660A (en) | Chinese medicament for treating tachycardia | |
| CN101843712A (en) | Chinese medicament for treating angina | |
| CN104547441A (en) | Medicine for treating tetanus | |
| CN101843645B (en) | Chinese medicament for treating tachycardia | |
| CN101843672B (en) | Chinese medicament for treating arteriosclerosis | |
| CN104922445A (en) | Chinese herbal compound composition with heart failure curing effect and preparation method and application thereof | |
| CN101843673B (en) | Chinese medicament for treating arteriosclerosis | |
| CN104606578A (en) | Traditional Chinese medicine composition for treating superficial thrombophebitis caused by medicine | |
| CN101849985B (en) | Chinese medicament for treating tachycardia | |
| CN102600342B (en) | Specific medicine for treating coronary disease | |
| CN101843758B (en) | Chinese medicament for treating coronary disease | |
| CN101843793B (en) | Chinese medicament for treating tachycardia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160323 Termination date: 20200102 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |